Every AI express, investors ask on the investor interaction platform: does the company plan to enter the field of second-generation sequencing?
Shenzhen New Industries Biomedical Engineering Co.Ltd(300832) ( Shenzhen New Industries Biomedical Engineering Co.Ltd(300832) . SZ) said on the investor interaction platform on March 27 that the company has no relevant plans at present. For the situation of the company’s products under research, please refer to the contents of reagents and instruments under research listed in the periodic report disclosed by the company.
